GSK’s ViiV and Medicines Patent Pool agree deal for HIV prevention - PMLiVE

The agreement aims to expand access to HIV prevention in the developing world

ViiV Healthcare, which is majority-owned by GSK, and the Medicines Patent Pool (MPP) have signed a new voluntary licensing agreement to expand access to HIV prevention in the developing world, GSK an… [+2141 chars]

full article...